BlackRock’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-415,316
Closed -$3.3M 5614
2025
Q2
$3.3M Sell
415,316
-3,829
-0.9% -$17.2K ﹤0.01% 3928
2025
Q1
$746K Sell
419,145
-1,557
-0.4% -$3.5K ﹤0.01% 4277
2024
Q4
$715K Sell
420,702
-1,845
-0.4% -$5.45K ﹤0.01% 4313
2024
Q3
$1.44M Buy
422,547
+17,504
+4% +$64.8K ﹤0.01% 4091
2024
Q2
$1.62M Sell
405,043
-471,989
-54% -$1.62M ﹤0.01% 4026
2024
Q1
$2.99M Sell
877,032
-42,100
-5% -$131K ﹤0.01% 3862
2023
Q4
$3.11M Buy
919,132
+71,853
+8% +$370K ﹤0.01% 3876
2023
Q3
$4.57M Buy
847,279
+25,827
+3% +$178K ﹤0.01% 3691
2023
Q2
$7.72M Buy
821,452
+719,366
+705% +$6.8M ﹤0.01% 3536
2023
Q1
$999K Sell
102,086
-305
-0.3% -$3.43K ﹤0.01% 4335
2022
Q4
$1.28M Buy
102,391
+666
+0.7% +$8.18K ﹤0.01% 4327
2022
Q3
$926K Sell
101,725
-2,498
-2% -$18.3K ﹤0.01% 4503
2022
Q2
$269K Sell
104,223
-199,466
-66% -$788K ﹤0.01% 4956
2022
Q1
$2.13M Buy
+303,689
New +$4.01M ﹤0.01% 4361

Other funds holding VIGL